Paul Hastings LLP represented Elanco US Inc., a division of Eli Lilly and Company, in the completion of its approximately $885 million acquisition of Boehringer Ingelheim…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now